KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

ClearPoint Neuro (CLPT) FCF Margin (2018 - 2025)

Historic FCF Margin for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to 37.47%.

  • ClearPoint Neuro's FCF Margin fell 225600.0% to 37.47% in Q3 2025 from the same period last year, while for Sep 2025 it was 40.41%, marking a year-over-year decrease of 111300.0%. This contributed to the annual value of 29.55% for FY2024, which is 307200.0% up from last year.
  • ClearPoint Neuro's FCF Margin amounted to 37.47% in Q3 2025, which was down 225600.0% from 28.38% recorded in Q2 2025.
  • ClearPoint Neuro's 5-year FCF Margin high stood at 14.91% for Q3 2024, and its period low was 107.91% during Q2 2021.
  • Over the past 5 years, ClearPoint Neuro's median FCF Margin value was 59.99% (recorded in 2022), while the average stood at 60.57%.
  • In the last 5 years, ClearPoint Neuro's FCF Margin crashed by -389800bps in 2021 and then skyrocketed by 568200bps in 2024.
  • Over the past 5 years, ClearPoint Neuro's FCF Margin (Quarter) stood at 83.84% in 2021, then increased by 28bps to 59.99% in 2022, then soared by 71bps to 17.47% in 2023, then fell by -15bps to 20.02% in 2024, then tumbled by -87bps to 37.47% in 2025.
  • Its FCF Margin stands at 37.47% for Q3 2025, versus 28.38% for Q2 2025 and 75.23% for Q1 2025.